| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-827X(02)01262-4 |
| P698 | PubMed publication ID | 12385522 |
| P2093 | author name string | M Teresa Marín | |
| Gloria E Salcedo | |||
| M Victoria Margarit | |||
| P2860 | cites work | Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use | Q34247844 |
| Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine | Q34999114 | ||
| A review of current drugs for migraine | Q37748453 | ||
| Pharmaceutical Applications of Solid Dispersion Systems | Q40000294 | ||
| PVP Solid Dispersions for the Controlled Release of Furosemide from a Floating Multiple-Unit System | Q60719672 | ||
| Thermal Behavior and Dissolution Properties of Naproxen From Binary and Ternary Solid Dispersions | Q63379408 | ||
| Characterization and evaluation of tenoxicam coprecipitates | Q74065414 | ||
| Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems | Q74065444 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 723-727 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Il Farmaco | Q3148453 |
| P1476 | title | Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone | |
| P478 | volume | 57 |
| Q46068423 | Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation. |
| Q38411322 | Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques |
| Q45974658 | Development and optimization of chemically stable lipid microspheres containing flunarizine. |
| Q51363069 | Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions. |
| Q51751453 | Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis. |
| Q44105266 | Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions |
| Q41919742 | Enhancement of dissolution profile by solid dispersion (kneading) technique |
| Q52682086 | Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer. |
| Q51057965 | Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres |
| Q41500235 | Improved albendazole dissolution rate in pluronic 188 solid dispersions. |
| Q42383199 | Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology |
| Q34184124 | Metal-free synthesis of allylic amines by cross-dehydrogenative-coupling of 1,3-diarylpropenes with anilines and amides under mild conditions |
| Q51103965 | Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats |
| Q64969549 | Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium. |
| Q43145008 | Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion. |
| Q36882074 | Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept |
| Q57349951 | Solubility enhancement of miconazole nitrate: binary and ternary mixture approach |
Search more.